Literature DB >> 25548389

Clinical research skills development program in cell-based regenerative medicine.

Ivonne Hernandez Schulman1, Viky Suncion2, Vasileios Karantalis2, Wayne Balkan2, Joshua M Hare2.   

Abstract

Cell-based therapy aimed at restoring organ function is one of the most exciting and promising areas of medical research. However, a novel intervention like cell-based therapy requires physician education and training. An increasing number of physicians untrained in regenerative medicine are using cell-based therapy to treat patients for a wide variety of chronic illnesses. The current lack of training for physicians in this area combined with the sharply increasing practice of regenerative medicine is concerning for a number of reasons, namely potential harm to patients and avoidable conflicts between governmental regulatory agencies and physicians. Academic medical fellowship training programs are needed that specifically prepare physicians for treating patients with cell-based therapies for various organ systems and chronic diseases. The National Heart, Lung, and Blood Institute established the Cardiovascular Cell Therapy Network to design and conduct clinical trials that advance the field of cell-based therapy for patients with cardiovascular disease. As part of the network, a two-year Clinical Research Skills Development Program was supported at two centers with the goal of training early career investigators in cell-based clinical and translational research. In this review, we describe the implementation of this training program at our institution with the purpose of promoting the further development of academic fellowship programs in cell-based regenerative medicine. ©AlphaMed Press.

Entities:  

Mesh:

Year:  2014        PMID: 25548389      PMCID: PMC4303357          DOI: 10.5966/sctm.2014-0144

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  33 in total

1.  Biomedicine. Selling the stem cell dream.

Authors:  Martin Enserink
Journal:  Science       Date:  2006-07-14       Impact factor: 47.728

Review 2.  Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research.

Authors:  Patricia Gálvez Martín; Adolfina Ruiz Martinez; Visitación Gallardo Lara; Beatriz Clares Naveros
Journal:  Clin Exp Med       Date:  2012-09-27       Impact factor: 3.984

Review 3.  Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy.

Authors:  Viky Y Suncion; Ivonne H Schulman; Joshua M Hare
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

4.  Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).

Authors:  Robert D Simari; Lemuel A Moyé; Sonia I Skarlatos; Stephen G Ellis; David X M Zhao; James T Willerson; Timothy D Henry; Carl J Pepine
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

5.  Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Authors:  Adam R Williams; Konstantinos E Hatzistergos; Benjamin Addicott; Fred McCall; Decio Carvalho; Viky Suncion; Azorides R Morales; Jose Da Silva; Mark A Sussman; Alan W Heldman; Joshua M Hare
Journal:  Circulation       Date:  2012-12-05       Impact factor: 29.690

6.  Medicine on the fringe: stem cell-based interventions in advance of evidence.

Authors:  Alan C Regenberg; Lauren A Hutchinson; Benjamin Schanker; Debra J H Mathews
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

7.  Myocardial infarction and intramyocardial injection models in swine.

Authors:  Frederic C McCall; Kartik S Telukuntla; Vasileios Karantalis; Viky Y Suncion; Alan W Heldman; Muzammil Mushtaq; Adam R Williams; Joshua M Hare
Journal:  Nat Protoc       Date:  2012-07-12       Impact factor: 13.491

8.  Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Authors:  Alan W Heldman; Darcy L DiFede; Joel E Fishman; Juan P Zambrano; Barry H Trachtenberg; Vasileios Karantalis; Muzammil Mushtaq; Adam R Williams; Viky Y Suncion; Ian K McNiece; Eduard Ghersin; Victor Soto; Gustavo Lopera; Roberto Miki; Howard Willens; Robert Hendel; Raul Mitrani; Pradip Pattany; Gary Feigenbaum; Behzad Oskouei; John Byrnes; Maureen H Lowery; Julio Sierra; Mariesty V Pujol; Cindy Delgado; Phillip J Gonzalez; Jose E Rodriguez; Luiza Lima Bagno; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Jose da Silva; Erica Anderson; Richard Schwarz; Adam Mendizabal; Joshua M Hare
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

9.  Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling.

Authors:  Adam R Williams; Viky Y Suncion; Frederic McCall; Danny Guerra; Jacques Mather; Juan P Zambrano; Alan W Heldman; Joshua M Hare
Journal:  J Am Heart Assoc       Date:  2013-05-17       Impact factor: 5.501

10.  Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development.

Authors:  Janis Ancans
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

View more
  4 in total

1.  The Pediatric Heart Network Scholar Award programme: a unique mentored award embedded within a multicentre network.

Authors:  L LuAnn Minich; Victoria L Pemberton; Lara S Shekerdemian; Morgan M Millar; Jane W Newburger; Andrew C Glatz; Eric M Graham; Richard J Czosek; Sara K Pasquali; Mike Seed; William L Border
Journal:  Cardiol Young       Date:  2018-04-16       Impact factor: 1.093

2.  A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells.

Authors:  Sudhish Sharma; Rachana Mishra; Grace E Bigham; Brody Wehman; Mohd M Khan; Huichun Xu; Progyaparamita Saha; Young Ah Goo; Srinivasa Raju Datla; Ling Chen; Mohan E Tulapurkar; Bradley S Taylor; Peixin Yang; Sotirios Karathanasis; David R Goodlett; Sunjay Kaushal
Journal:  Circ Res       Date:  2016-12-01       Impact factor: 17.367

Review 3.  How to establish infrastructures to achieve more efficient regenerative medicine?

Authors:  Babak Arjmand; Bagher Larijani; Sepideh Alavi-Moghadam; Hamid Reza Aghayan; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Mahmood Biglar; Mohsen Rajaeinejad; Fatemeh Fazeli Shouroki
Journal:  Cell Tissue Bank       Date:  2022-07-24       Impact factor: 1.752

4.  Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine.

Authors:  Ivonne Hernandez Schulman; Aisha Khan; Joshua M Hare
Journal:  Circ Res       Date:  2018-10-12       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.